139 related articles for article (PubMed ID: 8090811)
1. ICV injection of the serotonin 5-HT1B agonist CP-93,129 increases the secretion of ACTH, prolactin, and renin and increases blood pressure by nonserotonergic mechanisms.
Van de Kar LD; Alvarez Sanz MC; Yracheta JM; Kunimoto K; Li Q; Levy AD; Rittenhouse PA
Pharmacol Biochem Behav; 1994 Jun; 48(2):429-36. PubMed ID: 8090811
[TBL] [Abstract][Full Text] [Related]
2. Central stimulation of renin secretion through serotonergic, noncardiovascular mechanisms.
Rittenhouse PA; Bakkum EA; Levy AD; Li Q; Yracheta JM; Kunimoto K; van de Kar LD
Neuroendocrinology; 1994 Aug; 60(2):205-14. PubMed ID: 7969778
[TBL] [Abstract][Full Text] [Related]
3. WAY-100635 inhibits 8-OH-DPAT-stimulated oxytocin, ACTH and corticosterone, but not prolactin secretion.
Vicentic A; Li Q; Battaglia G; Van de Kar LD
Eur J Pharmacol; 1998 Apr; 346(2-3):261-6. PubMed ID: 9652368
[TBL] [Abstract][Full Text] [Related]
4. Neurons in the hypothalamic paraventricular nucleus mediate the serotonergic stimulation of prolactin secretion via 5-HT1c/2 receptors.
Rittenhouse PA; Levy AD; Li Q; Bethea CL; Van de Kar LD
Endocrinology; 1993 Aug; 133(2):661-7. PubMed ID: 8344205
[TBL] [Abstract][Full Text] [Related]
5. Repeated cocaine exposure inhibits the adrenocorticotropic hormone response to the serotonin releaser d-fenfluramine and the 5-HT1A agonist, 8-OH-DPAT.
Levy AD; Li Q; Van de Kar LD
Neuropharmacology; 1994; 33(3-4):335-42. PubMed ID: 7984271
[TBL] [Abstract][Full Text] [Related]
6. Investigation of the role of 5-HT3 receptors in the secretion of prolactin, ACTH and renin.
Levy AD; Li Q; Rittenhouse PA; Van de Kar LD
Neuroendocrinology; 1993 Jul; 58(1):65-70. PubMed ID: 8264857
[TBL] [Abstract][Full Text] [Related]
7. Neuroendocrine profile of the potential anxiolytic drug S-20499.
Levy AD; Li Q; Gustafson M; Van de Kar LD
Eur J Pharmacol; 1995 Feb; 274(1-3):141-9. PubMed ID: 7768266
[TBL] [Abstract][Full Text] [Related]
8. Effects of various serotonin receptor subtype-selective antagonists alone and on m-chlorophenylpiperazine-induced neuroendocrine changes in rats.
Aulakh CS; Hill JL; Murphy DL
J Pharmacol Exp Ther; 1992 Nov; 263(2):588-95. PubMed ID: 1432690
[TBL] [Abstract][Full Text] [Related]
9. Neuroendocrine and cardiovascular effects of serotonin: selective role of brain angiotensin on vasopressin.
Saydoff JA; Rittenhouse PA; Carnes M; Armstrong J; Van De Kar LD; Brownfield MS
Am J Physiol; 1996 Mar; 270(3 Pt 1):E513-21. PubMed ID: 8638700
[TBL] [Abstract][Full Text] [Related]
10. Role of various 5-HT receptor subtypes in mediating neuroendocrine effects of 1-(2,5-dimethoxy-4-methylphenyl)-2-aminopropane (DOM) in rats.
Aulakh CS; Mazzola-Pomietto P; Hill JL; Murphy DL
J Pharmacol Exp Ther; 1994 Oct; 271(1):143-8. PubMed ID: 7965707
[TBL] [Abstract][Full Text] [Related]
11. Effects of serotonin 5-HT1B receptor ligands on the cocaine- and food-maintained self-administration in rats.
Przegaliński E; Gołda A; Frankowska M; Zaniewska M; Filip M
Eur J Pharmacol; 2007 Mar; 559(2-3):165-72. PubMed ID: 17291490
[TBL] [Abstract][Full Text] [Related]
12. Adrenocorticotropic hormone secretion in rats induced by stimulation with serotonergic compounds. hsj@mfi.ku.dk.
Jørgensen H; Knigge U; Kjaer A; Warberg J
J Neuroendocrinol; 1999 Apr; 11(4):283-90. PubMed ID: 10223282
[TBL] [Abstract][Full Text] [Related]
13. The role of 5-HT1B receptors in the regulation of serotonin cell firing and release in the rat brain.
Adell A; Celada P; Artigas F
J Neurochem; 2001 Oct; 79(1):172-82. PubMed ID: 11595769
[TBL] [Abstract][Full Text] [Related]
14. Neuroendocrine evidence for denervation supersensitivity of serotonin receptors: effects of the 5-HT agonist RU 24969 on corticotropin, corticosterone, prolactin and renin secretion.
Van de Kar LD; Carnes M; Maslowski RJ; Bonadonna AM; Rittenhouse PA; Kunimoto K; Piechowski RA; Bethea CL
J Pharmacol Exp Ther; 1989 Nov; 251(2):428-34. PubMed ID: 2553918
[TBL] [Abstract][Full Text] [Related]
15. Mediation of ACTH and prolactin responses to 5-HTP by 5-HT2 receptors.
Gartside SE; Cowen PJ
Eur J Pharmacol; 1990 Apr; 179(1-2):103-9. PubMed ID: 2163847
[TBL] [Abstract][Full Text] [Related]
16. Studies on the neuroendocrine role of serotonin.
Jørgensen HS
Dan Med Bull; 2007 Nov; 54(4):266-88. PubMed ID: 18208678
[TBL] [Abstract][Full Text] [Related]
17. Anticonvulsant effect of the selective 5-HT1B receptor agonist CP 94253 in mice.
Wesołowska A; Nikiforuk A; Chojnacka-Wójcik E
Eur J Pharmacol; 2006 Jul; 541(1-2):57-63. PubMed ID: 16765343
[TBL] [Abstract][Full Text] [Related]
18. Evidence that the serotonin agonist, DOI, increases renin secretion and blood pressure through both central and peripheral 5-HT2 receptors.
Rittenhouse PA; Bakkum EA; Van de Kar LD
J Pharmacol Exp Ther; 1991 Oct; 259(1):58-65. PubMed ID: 1920135
[TBL] [Abstract][Full Text] [Related]
19. Repeated injections of cocaine inhibit the serotonergic regulation of prolactin and renin secretion in rats.
Levy AD; Rittenhouse PA; Li Q; Bonadonna AM; Alvarez Sanz MC; Kerr JE; Bethea CL; van de Kar LD
Brain Res; 1992 May; 580(1-2):6-11. PubMed ID: 1504817
[TBL] [Abstract][Full Text] [Related]
20. Infusion of the serotonin1B (5-HT1B) agonist CP-93,129 into the parabrachial nucleus potently and selectively reduces food intake in rats.
Lee MD; Aloyo VJ; Fluharty SJ; Simansky KJ
Psychopharmacology (Berl); 1998 Apr; 136(3):304-7. PubMed ID: 9566817
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
